The cases of MDS with ring sideroblasts (MDS-RS) traditionally require 15% ring siderblasts from the entire erythroid precursors; however, in the presence of the SF3B1 mutation, the cutoff requirement goes down to only 5% [6]. Here, SF3B1 is linked to myelodysplastic syndrome.